medmix AG
MEDX.SW
| Exchange: | SW |
| Currency | Swiss Franc |
| Open Figi: | BBG011FFPBC1 |
| ISIN: | CH1129677105 |
| Primary Ticker: | MEDX.SW |
| Fiscal Year End: | December |
| Sector: | Industrials |
| Industry: | Specialty Industrial Machinery |
| Gic Sector: | Industrials |
| Gic Group: | Capital Goods |
| Gic Industry: | Machinery |
| Gic Sub Industry: | Industrial Machinery & Supplies & Components |
| Description: | Medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland. |
| Address: | Neuhofstrasse 20, Baar, Switzerland, 6340 |
| Website: | https://www.medmix.swiss |
| Full Time Employees: | 2695 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 390347840 |
| Market Capitalization Mln: | 390.34 |
| EBITDA: | 63500000 |
| Wall Street Target Price: | 25 |
| Book Value: | 11.29 |
| Dividend Share: | 0.5 |
| Dividend Yield: | 0.05 |
| Earnings Share: | -0.05 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.00 |
| Operating Margin TTM: | 0.05 |
| Return On Assets TTM: | 0.01 |
| Return On Equity TTM: | -0.00 |
| Revenue TTM: | 479700000 |
| Revenue Per Share TTM: | 11.35 |
| Quarterly Revenue Growth YOY: | -0.02 |
| Gross Profit TTM: | 172800000 |
| Diluted Eps TTM: | -0.05 |
| Quarterly Earnings Growth YOY: | -0.33 |
Valuation
| Forward PE: | 9.57 |
| Price Sales TTM: | 0.81 |
| Price Book MRQ: | 0.84 |
| Enterprise Value: | 612732266 |
| Enterprise Value Revenue: | 1.27 |
| Enterprise Value Ebitda: | 8.24 |
Shares
| Shares Outstanding: | 40788700 |
| Shares Float: | 23987438 |
| Percent Insiders: | 40.71 |
| Percent Institutions: | 25.15 |
Technicals
| Beta: | 0.78 |
| 52 Week High: | 18.93 |
| 52 Week Low: | 9.25 |
| 50 Day MA: | 10.01 |
| 200 Day MA: | 13.74 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.5 |
| Forward Annual Dividend Yield: | 0.05 |
| Payout Ratio: | 50 |
| Dividend Date: | 2024-04-30 |
| Ex Dividend Date: | 2024-04-26 |
Earnings
| Report Date: | 2023-02-22 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Eps Actual: | -0.3 |
| Eps Difference: | -0.3 |
| Report Date: | 2022-08-04 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | CHF |
| Eps Actual: | 0.58 |
| Eps Difference: | 0.58 |
| Report Date: | 2022-02-21 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | CHF |
| Eps Actual: | 0.44 |
| Eps Difference: | 0.44 |
| Report Date: | 2021-08-20 |
| Date: | 2021-06-30 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Eps Actual: | 0.12 |
| Eps Difference: | 0.12 |
| Date: | 2022-12-31 |
| Eps Actual: | 0.2 |
| Date: | 2021-12-31 |
| Eps Actual: | 0.5 |